SL PHARM(SZ:002038) Xin Lang Cai Jing·2025-08-27 01:08Group 1 - The core viewpoint of the article is that institutional investors have increased their holdings in Shuanglu Pharmaceutical, with a total of 1.88 billion shares held, representing 18.33% of the company's total equity as of August 26, 2025 [1] - The proportion of institutional holdings has risen by 0.42 percentage points compared to the previous quarter [1] - Among public funds, only one fund, the Southern CSI 1000 ETF, increased its holdings, with an increase ratio of 0.12% [1] Group 2 - One foreign fund, Hong Kong Central Clearing Limited, increased its holdings by 0.23% compared to the previous period [1] - A total of six institutional investors are reported to hold shares in Shuanglu Pharmaceutical [1] - New institutional investors include the Southern CSI 1000 ETF and Haitong Zhixuan B, which were newly disclosed in this period [1]